News & Events
From diagnosis and symptoms to risk factors and management, this course is for anyone wanting to learn…
New survey launched by the International Progressive MS Alliance
Multiple Sclerosis (MS) treatments added to WHO’s Essential Medicines List for the first time
Global MS experts update recommendations for the differential diagnosis of MS
Professor Montalban wins the 2023 lifetime achievement award for outstanding research into the understanding and treatment of…
Research advances that could lead to breakthrough treatments in progressive MS
Importance of training and education for healthcare professionals is highlighted in new publication
Your update from MS organisations in the Arab Region
Agreement seeks to coordinate resources on the highest potential research
MSIF and neurological organisations' statement during the Essential Medicines List Committee open session
A look at some of MSSI’s most exciting advocacy work and MSIF’s visit to Delhi and Mumbai.
MSIF’s Organisational Development and Movement Building (ODMB) team visited MS organisations in Egypt and Jordan to learn…